Tag Archives: Federal Circuit

Appeals Court Overturns Stem Cell Ban

On April 29th, in Sherley v. Sebelius, the U.S. Court of Appeals for the D.C. Cir., (a copy is available at the end of this post) overturned the injunction imposed by the district court, which had blocked the implementation of … Continue reading

Posted in Stem Cells/Cloning | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Myriad Oral Arguments – Section 101 vs. Chemistry 101?

After listening to the IPO webinar and reading the detailed account by Kevin Noonan in PatentDocs on the Myriad oral arguments, I was somewhat heartened to “hear” the Fed. Cir. panel moving toward “getting it” regarding what an isolated DNA … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , | 2 Comments

Federal Court Hears Myriad Gene Case This Morning

The following is a guest post from Ann McCrackin. I attended oral arguments at the CAFC on Monday for Association for Molecular Pathology v. Myriad Genetics, Inc.   The three-judge panel included Judge Bryson, Judge Lourie and Judge Moore.  Most of the … Continue reading

Posted in Burden of Proof | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Microsoft V. i4i – Prosecution And The “Variable Proof Regime”

The Government recently weighed in on this important appeal with its amicus brief, signed by Neal Katyal, Acting Solicitor General. (A copy can be found at the end of this post.) The question posed is simply: “Whether, when the defendant … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , | Leave a comment